Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05411393 · ClinicalTrials.gov registry record · NA

Synergizing Home Health Rehabilitation Therapy

A NA study of Frailty and Rehabilitation, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
47
Enrollment target
1
Study location

NCT05411393 is a NA study of Frailty and Rehabilitation that has completed, run by University of Florida. The registered enrollment target is 47 participants, below the 1,505-participant average among 48 other Frailty trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05411393, a NA study of Frailty and Rehabilitation, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to pilot test an ADL (activities of daily living)-enhanced program as an adjuvant therapy to usual home health rehabilitation to improve patient outcomes. The project will compare the ADL-enhanced program plus usual care with usual care using an RCT design in home health patients.

Interventions

  • OTHER ADL-enhanced program
  • OTHER Usual home health rehabilitation therapy

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2022-10-06
Est. Completion 2025-03-15
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05411393

The ClinicalTrials.gov registry entry for NCT05411393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,505-participant average among 48 other Frailty trials with a reported enrollment target (97% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Frailty appearing as the primary indexed condition, and to 2 interventions - of which ADL-enhanced program is the first listed.

NCT05411393 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05411393 about?

NCT05411393 is a clinical study titled "Synergizing Home Health Rehabilitation Therapy". The objective of this project is to pilot test an ADL (activities of daily living)-enhanced program as an adjuvant therapy to usual home health rehabilitation to improve patient outcomes. The project will compare the ADL-enhanced program plus usual care with usual care using an RCT design in home he...

What is the current status of trial NCT05411393?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2022-10-06. Estimated completion is 2025-03-15.

What conditions does trial NCT05411393 study?

This clinical trial studies the following conditions: Frailty, Rehabilitation, Frail Elderly, Occupational Therapy, Functional Status.

What interventions are being tested in trial NCT05411393?

The interventions under investigation include: ADL-enhanced program (OTHER), Usual home health rehabilitation therapy (OTHER).

Who is sponsoring clinical trial NCT05411393?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05411393 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frailty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.